Day One Biopharmaceuticals, Inc. (DAWN) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts DAWN Hot Sheet
Join SI Premium – FREE
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) reported Q3 EPS of ($0.54), $0.05 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Day One Biopharmaceuticals, Inc. (DAWN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Conagra Brands stock rises 3% on earnings beat, reaffirmed guidance
- J.P. Morgan favors European platforms on growth, sees UK backdrop as drag
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
